scispace - formally typeset
Journal ArticleDOI

Kinetic Inertness and Electrochemical Behavior of Copper(II) Tetraazamacrocyclic Complexes: Possible Implications for in Vivo Stability

TLDR
In this article, the kinetic inertness of copper(II) complexes of carboxymethyl-armed cyclams and cyclens in 5 M HCl was determined confirming that the complex derived from cross-bridged cyclam (Cu-CB-TE2A) is by far the most resistant to acid decomplexation.
Abstract
The kinetic inertness of copper(II) complexes of several carboxymethyl-armed cyclams and cyclens in 5 M HCl have been determined confirming that the complex derived from cross-bridged cyclam (Cu-CB-TE2A) is by far the most resistant to acid decomplexation. FT-IR studies in D2O solution revealed its unique resistance to full carboxylate protonation and its retention of coordination by both pendant arms even in 1 M DCl. The X-ray structure of its monoprotonated form, [Cu-CB-TE2AH]+, also established full coordination by both COO– and COOH pendant arms in the solid state. Cyclic voltammograms of four carboxymethyl pendant-armed cyclam and cyclen complexes in aqueous solution were obtained with only Cu-CB-TE2A displaying a quasi-reversible CuII/CuI reduction wave. These indicators correlate with the superior in vivo behavior of this complex and its bifunctional conjugate. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)

read more

Citations
More filters
Journal ArticleDOI

Coordinating Radiometals of Copper, Gallium, Indium, Yttrium and Zirconium for PET and SPECT Imaging of Disease

TL;DR: SPECT and PET technology has been around for decades, but its use remained limited because of the limited availability of relevant isotopes which had to be produced in nuclear reactors or particle accelerators, but the introduction of the small biomedical cyclotron, the self-contained radionuclide generator and the dedicated small animal or clinical SPECT andPET scanners to hospitals and research facilities has increased the demand for SPect and PET isotopes.
Journal ArticleDOI

Matching chelators to radiometals for radiopharmaceuticals.

TL;DR: This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals.
Journal ArticleDOI

Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research

TL;DR: CoCopper-64 (T1/2) = 12.7 hours; β+, 0.653 MeV [17.8 %]; β−, 0.579 MEV [38.4 %]) has decay characteristics that allow for positron emission tomography (PET) imaging and targeted radiotherapy of cancer as discussed by the authors.
Journal ArticleDOI

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

TL;DR: Specific examples of PET imaging with new and improved (64)Cu-based radiopharmaceuticals are discussed, highlighting the study of some of the key cancer biomarkers, such as epidermal growth-factor receptor (EGFR), somatostatin receptors (SSRs), and integrin alpha(v)beta(3).
Journal ArticleDOI

Copper chelation chemistry and its role in copper radiopharmaceuticals.

TL;DR: The necessary characteristics of an effective ( 64)Cu chelator are discussed, while highlighting the development and evaluation of (64)Cu-complexes attached to biologically-targeted ligands.
References
More filters
Journal ArticleDOI

Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes

TL;DR: Results indicate that the structurally reinforcing cross-bridge enhances in vivo stability by reducing metal loss to protein in both the cyclam and cyclen cross-bridged (64)Cu complexes and that ( 64)Cu-CB-TE2A is superior to (64)-CB-DO2A in that regard.
Journal ArticleDOI

Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging

TL;DR: This review will discuss the non-technetium-labeled radiometal- labeled agents used in gamma scintigraphy and positron emission tomography (PET) and their uses in nuclear medicine.
Journal ArticleDOI

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

TL;DR: Evaluating the metabolic fate of copper radiopharmaceuticals demonstrated that Cu(II) dissociates from macrocyclic chelators such as TETA and binds to proteins in high concentrations, namely SOD in rat liver.
Journal ArticleDOI

Complexes of tetraazacycles bearing methylphosphinic/phosphonic acid pendant arms with copper(II), zinc(II) and lanthanides(III). A comparison with their acetic acid analogues

TL;DR: In this paper, a comparison of complexing properties of cyclen and cyclam derivatives containing acetic acid pendant arms was made mainly with complexes of copper and lanthanides due to their applications in medicine.
Journal ArticleDOI

Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands

TL;DR: The rapid clearance of the (64)Cu-2 complex from the blood and liver, as well as liver metabolism experiments in rats, suggests that it is highly stable in vivo, and a bifunctional chelator of 2 is a significant candidate for labeling copper radionuclides to biological molecules for diagnostic imaging and targeted radiotherapy.
Related Papers (5)